Vanguard Personalized Indexing Management, LLC Igm Biosciences, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,919 shares of IGMS stock, worth $18,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,919
Previous 13,841
7.79%
Holding current value
$18,947
Previous $15,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IGMS
# of Institutions
61Shares Held
14.9MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.1MShares$5.2 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.13 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.75 Million0.4% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.12 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY855KShares$1.09 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $36.8M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...